ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00563355
Recruitment Status : Completed
First Posted : November 26, 2007
Last Update Posted : June 16, 2011
Sponsor:
Collaborator:
The Hong Kong Society of Nephrology
Information provided by:
Hospital Authority, Hong Kong

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : November 2003